Market Cap (In USD)
274.88 Million
Revenue (In USD)
216 Thousand
Net Income (In USD)
-21.75 Million
Avg. Volume
23.35 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.69-13.29
- PE
- -
- EPS
- -
- Beta Value
- 0.879
- ISIN
- US08205P2092
- CUSIP
- 08205P100
- CIK
- 1808898
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Jerel A. Banks M.D., Ph.D.
- Employee Count
- -
- Website
- https://benitec.com
- Ipo Date
- 2014-06-24
- Details
- Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
More Stocks
-
GMNI
-
NLFL
-
BCRDBlueone Card Inc.
BCRD
-
7539
-
VASUPRADASHRI VASUPRADA PLANTATIONS LIM
VASUPRADA
-
GANDHITUBEGandhi Special Tubes Limited
GANDHITUBE
-
PANAENERGPanasonic Energy India Co. Ltd.
PANAENERG
-
ELD